Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Seom guidelines for the treatment of gastric cancer 2015
M Martin-Richard1, A Custodio2, C García-Girón3
1Medical Oncology Department, Hospital de la Santa Creu I Sant Pau, 167, 08025, Barcelona, Spain. mmartinri@santpau.cat.
Abstract:
Gastric cancer is the fourth cause of death by cancer in Spain and a significant medical problem. Molecular biology results evidence that gastroesophageal junction tumors and gastric cancer should be considered as two independent entities with a different prognosis and treatment approach. Endoscopic resection in very early tumors is feasible. Neoadjuvant and adjuvant therapy in locally advanced resectable tumor increase overall survival and should be considered standard treatments. In stage IV tumors, platinum-fluoropyrimidine-based schedule, with trastuzumab in HER2-overexpressed tumors, is the first-line treatment. Different therapies in second line have demonstrated in randomized studies their clear benefit in survival improvement.
Insights
Gastric cancer is a major health issue, with distinct treatments for gastroesophageal junction tumors. Early endoscopic resection and neoadjuvant/adjuvant therapies improve survival for advanced gastric cancer.
Area of Science:
- Oncology
- Gastroenterology
- Molecular Biology
Background:
- Gastric cancer represents a significant mortality cause in Spain.
- Emerging molecular data suggest gastroesophageal junction tumors are distinct from gastric cancer, necessitating different prognoses and treatments.
- Early-stage gastric tumors are amenable to endoscopic resection.
Purpose of the Study:
- To review current treatment strategies for gastric cancer, including early, locally advanced, and stage IV disease.
- To highlight the importance of differentiating gastroesophageal junction tumors from gastric cancer.
- To summarize evidence supporting neoadjuvant/adjuvant therapies and first- and second-line treatments for advanced gastric cancer.
Main Methods:
- Literature review of molecular biology findings and clinical studies on gastric cancer and gastroesophageal junction tumors.
- Analysis of treatment outcomes for various stages of gastric cancer.
- Evaluation of therapeutic regimens, including endoscopic resection, neoadjuvant/adjuvant therapy, and chemotherapy (platinum-fluoropyrimidine, trastuzumab).
Main Results:
- Endoscopic resection is a viable option for very early gastric tumors.
- Neoadjuvant and adjuvant therapies demonstrably improve overall survival in locally advanced, resectable gastric cancer.
- Platinum-fluoropyrimidine regimens, augmented with trastuzumab for HER2-overexpressing tumors, are the standard first-line treatment for stage IV gastric cancer.
- Second-line therapies have shown significant survival benefits in randomized studies.
Conclusions:
- Gastric cancer and gastroesophageal junction tumors require distinct management approaches.
- Standardized treatment protocols, including surgery, neoadjuvant/adjuvant therapies, and targeted chemotherapy, are crucial for improving patient survival.
- Ongoing research into second-line treatments offers further improvements for advanced gastric cancer patients.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...

